Electrospray ionisation: difference between revisions
Diff·revision 9 → 10·08:45, 22 Jan 2025
Difference between revision 9 and revision 10 of Electrospray ionisation. 5 lines changed; the page grew by 111 bytes.
| Revision 9 — 04:41, 31 Dec 2024 SigFigSindri (talk) rm the assertion that two laboratories must agree; they need not 3,115 bytes +514 | Revision 10 — 08:45, 22 Jan 2025 PeakShapePol (talk) add the reference standard and its traceability 3,226 bytes +111 | ||
|---|---|---|---|
| 33 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 33 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| 34 | 34 | ||
| + | 35 | == See also == | |
| + | 36 | * [[Mass spectrometry]] | |
| + | 37 | * [[Liquid chromatography-mass spectrometry]] | |
| + | 38 | * [[Reverse-phase HPLC]] | |
| + | 39 | ||
| 35 | {{DEFAULTSORT:Electrospray ionisation}} | 40 | {{DEFAULTSORT:Electrospray ionisation}} |
| 36 | [[Category:Mass spectrometry]] | 41 | [[Category:Mass spectrometry]] |